FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used in treating patients with breast cancer. A method involves chemotherapy, and 30 minutes prior to cytostatics infusion on autologous liquid tissue - autoblood, autoplasma, with a disposable syringe, 1% ATP 2 ml is introduced in a mammary gland in a peritumour area, 0.5 ml in 4 various points which are changed before the next infusions of chemopreparations with covering the whole perimetre of a tumour.
EFFECT: use of the invention allows creating temporary metabolic acidosis, promoting tunmour necrosis and apoptosis process activation, that in turn intensifies a damaging effect of chemotherapy.
4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438659C1 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD OF NEOADJUVANT CHEMOTHERAPY OF MAMMARY GLAND CANCER | 2007 |
|
RU2338545C1 |
BREAST CANCER CHEMOTHERAPY PROCEDURE | 2008 |
|
RU2372917C1 |
METHOD FOR TREATING THE CASES OF NON-OPERABLE CANCER METASTASIZING INTO LYMPH NODES | 2002 |
|
RU2218186C2 |
METHOD FOR TREATMENT OF ABDOMINAL CAVITY PRIMARY AND METASTATIC TUMORS | 2003 |
|
RU2272655C2 |
METHOD TO TREAT MAMMARY GLAND CANCER | 2000 |
|
RU2178294C2 |
METHOD OF TREATING MALIGNANT NEW GROWTHS IN EXPERIMENT | 2011 |
|
RU2484539C1 |
METHOD FOR TREATING TUMOR PLEURITIS | 2002 |
|
RU2225228C2 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
Authors
Dates
2012-01-10—Published
2010-05-04—Filed